These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 5815597)

  • 1. [Clinical evaluation of lysozyme ophthalmic solution (MT-L)].
    Matsushita K; Tani Y; Miyaura K
    Nihon Ganka Kiyo; 1969 Jan; 20(1):34-40. PubMed ID: 5815597
    [No Abstract]   [Full Text] [Related]  

  • 2. [Double-blind clinical study on the effect of lysozyme in acute conjunctivitis].
    Matter M; Scheppens JM
    Schweiz Rundsch Med Prax; 1982 Oct; 71(43):1692-5. PubMed ID: 6760170
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical experience with an ophthalmic solution "My Tear" (0.1 percent lysozyme chloride)].
    Nakazawa T; Inatomi M
    Nihon Ganka Kiyo; 1967 Oct; 18(10):1079-83. PubMed ID: 5627138
    [No Abstract]   [Full Text] [Related]  

  • 4. [Initial clinical research on lysozyme ampicillanate in ophthalmology].
    Guffanti A
    Minerva Oftalmol; 1968; 10(4):139-47. PubMed ID: 5717787
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic experiences with the ophthalmic solution Oxy Biciron].
    Hildebrandt PG
    Med Monatsschr; 1972 Dec; 26(12):579-81. PubMed ID: 4663634
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antimicrobial agents in eye infections].
    Polak BC
    Ned Tijdschr Geneeskd; 1988 Sep; 132(38):1731-5. PubMed ID: 3173564
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ophthalmic solution of lincomycin].
    Suda S
    Ganka; 1969 Nov; 11(11):892-900. PubMed ID: 5391926
    [No Abstract]   [Full Text] [Related]  

  • 8. [Experiences in clinic and practice with the drugs Predni and Predni aguos. in Ophtiole].
    Steck K; Zadil E
    Z Allgemeinmed; 1971 Jul; 47(20):1050-1. PubMed ID: 5569047
    [No Abstract]   [Full Text] [Related]  

  • 9. Trimethoprim-polymyxin ophthalmic solution versus chloramphenicol ophthalmic solution in the treatment of bacterial conjunctivitis.
    van Rensburg SF; Gibson JR; Harvey SG; Burke CA
    Pharmatherapeutica; 1982; 3(4):274-7. PubMed ID: 6292957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis.
    Erjongmanee S; Kasetsuwan N; Phusitphoykai N; Puangsricharern V; Pariyakanok L
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S83-90. PubMed ID: 16083168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ciprofloxacin eyedrops. Ciprofloxacin for topical therapy].
    Ophthalmologe; 1995 Jun; 92(3 Suppl):1-8. PubMed ID: 9131834
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical evaluation of santemycin eye drops in external infections of the eye (author's transl)].
    Uchida Y; Yamanishi R; Matsuda H; Nerome K; Tazawa Y; Shimada K; Kitano S; Chuma K; Tokuda H; Hirayama N; Kubota O; Tanaka N; Sasaki T; Ishikawa S; Miyata M; Yoshida H; Fukuda T; Oishi M; Nishizuka K; Ichikawa H; Murakami M; Hara J; Mitsui Y; Shiota H; Tsutsui J; Kobayashi S; Shoji K; Okamura R; Kamata R; Matsumoto K; Kotera K
    Nippon Ganka Gakkai Zasshi; 1981; 85(11):2030-45. PubMed ID: 7337125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Allergy to eyedrops and ointments in patients with chronic conjunctivitis].
    Afzelius H
    Ugeskr Laeger; 1979 Apr; 141(14):918-20. PubMed ID: 425193
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antitubercular treatment of phlyctenular conjunctivitis and keratitis].
    Lenkiewicz E; Lenkiewicz B
    Pediatr Pol; 1970 Jan; 45(1):39-44. PubMed ID: 5413693
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of filamentous keratitis with hypertonic sodium chloride].
    Mouilleau D; Lemeur Y; Baikoff G
    Bull Soc Ophtalmol Fr; 1984 Jan; 84(1):109-12. PubMed ID: 6529819
    [No Abstract]   [Full Text] [Related]  

  • 16. Dimethyl sulfoxide in ophthalmology, with especial reference to possible toxic effects.
    Gordon DM
    Ann N Y Acad Sci; 1967 Mar; 141(1):392-401. PubMed ID: 5232250
    [No Abstract]   [Full Text] [Related]  

  • 17. [Clinical results of the local use of a combination of lysozyme and papain in O.R.L].
    Charachon R; Gagnon J
    Sem Ther; 1963 Nov; 39(9):562-5. PubMed ID: 5877593
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxymetazoline ophthalmic solution versus naphazoline solution in non-infectious conjunctivitis.
    Rybiczka R; Mauracher E
    Pharmatherapeutica; 1983; 3(6):376-81. PubMed ID: 6353428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prolonged effectiveness of bepotastine besilate ophthalmic solution for the treatment of ocular symptoms of allergic conjunctivitis.
    Williams JI; Kennedy KS; Gow JA; Torkildsen GL; Abelson MB; Gomes PJ; McNamara TR;
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):385-93. PubMed ID: 21649522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: a phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children.
    Abelson MB; Torkildsen GL; Williams JI; Gow JA; Gomes PJ; McNamara TR;
    Clin Ther; 2009 Sep; 31(9):1908-21. PubMed ID: 19843481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.